Skip to main content

Table 2 P16 and Ki-67 positivity in histology categories stratified by age and HPV infection

From: Combining HPV DNA load with p16/Ki-67 staining to detect cervical precancerous lesions and predict the progression of CIN1–2 lesions

Category

Cervicitis

CIN1

CIN2

CIN3

cancer

Total

HPV+ / < 30

4

6

3

4

0

17

% (p16+, Ki-67+, D+)

0, 25, 0

50, 66.7, 16.7

100, 100, 100

75, 100, 75

N/A

52.9, 70.6, 41.2

HPV- / < 30

2

3

1

0

0

6

% (p16+, Ki-67+, D+)

0, 50, 0

0, 66.7, 0

100, 100, 100

N/A

N/A

16.7, 66.7, 16.7

HPV+ / ≥30, < 45

18

28

27

51

9

133

% (p16+, Ki-67+, D+)

11.1, 66.7, 11.1

35.7, 60.7, 25

81.5, 85.2, 70.4

86.3, 96.1, 84.3

100, 100, 100

64.7, 82.7, 59.4

HPV- / ≥30, < 45

13

13

9

1

1

37

% (p16+, Ki-67+, D+)

0, 38.5, 0

0, 69.2, 0

76.9, 88.9, 76.9

100, 100, 100

100, 100, 100

27, 70.3, 27

HPV+ /≥45

27

16

26

32

20

121

% (p16+, Ki-67+, D+)

11.1, 40.7, 7.4

37.5, 87.5, 37.5

80.8, 88.5, 73.1

96.9, 100, 96.9

95, 100, 95

66.1, 82.6, 63.6

HPV- / ≥45

20

11

2

1

2

36

% (p16+, Ki-67+, D+)

20, 55, 20

27.3, 90.9, 27.3

50, 100, 50

100, 100, 100

100, 100, 100

30.6, 72.2, 30.6

Total

84

77

68

89

32

350

% (p16+, Ki-67+, D+)

10.7 48.8, 9.5

28.6, 72.7, 22.1

80.9, 88.2, 73.5

89.9, 97.8, 88.8

96.9, 100, 96.9

56.3, 78.9, 52.9